Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy

OBJECTIVE: Present rationale, guidelines, and results of ranibizumab treatment for proliferative diabetic retinopathy (PDR) in Diabetic Retinopathy Clinical Research Network (DRCR.net) Protocol S. DESIGN: Post hoc analyses from a randomized clinical trial. PARTICIPANTS: Three hundred and five partic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ophthalmology
Autores principales: Sun, Jennifer K., Glassman, Adam R., Beaulieu, Wesley T., Stockdale, Cynthia R., Bressler, Neil M., Flaxel, Christina, Gross, Jeffrey G., Shami, Michel, Jampol, Lee M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6916649/
https://ncbi.nlm.nih.gov/pubmed/30096354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2018.08.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares